Publications Database

Belsito K. M. et al. (2001)

Lamotrigine therapy for autistic disorder: a randomized, double-blind, placebo-controlled trial.

Journal of Autism and Developmental Disorders

31(2), pp. 175-181

Read Abstract (New Window)

Canitano R. (2015)

Mood stabilizers in children and adolescents with autism spectrum disorders.

Clinical Neuropharmacology

September, 38(5), pp. 177-182.

Read Abstract (New Window)

Chadwick D. , MRC Antiepileptic Drug Withdrawal Study Group (1999)

Does withdrawal of different antiepileptic drugs have different effects on seizure recurrence? Further results from the MRC Antiepileptic Drug Withdrawal Study.

Brain

122(3), pp. 441-448

Read Abstract (New Window) Read Full (New Window)

Coskun M. , Bozkurt H. , Zoroglu S. (2009)

Possible lamotrigine-induced mania in a child with autism spectrum disorder and epilepsy.

Journal of Clinical Psychopharmacology

29(5), pp. 508-509

Davazno P. , King B. H. (1996)

Open trial lamotrigine in the treatment of self-injurious behavior in an adolescent with profound mental retardation.

Journal of Child and Adolescent Psychopharmacology

6(4), pp. 273-279

Read Abstract (New Window)

Doyle C. A. , McDougle C. J. (2012)

Pharmacotherapy to control behavioral symptoms in children with autism.

Expert Opinion on Pharmacotherapy

13(11), pp. 1615-1629.

Read Abstract (New Window)

Frye R. E. et al. (2013)

A review of traditional and novel treatments for seizures in autism spectrum disorder: Findings from a systematic review and expert panel.

Frontiers in Public Health

Read Abstract (New Window) Read Full (New Window)

Hirota T. et al. (2014)

Antiepileptic medications in autism spectrum disorder: A systematic review and meta-analysis.

Journal of Autism and Developmental Disorders

44(4), pp. 948-957.

Read Abstract (New Window)

Kumar B. et al. (2012)

Drug therapy in autism: a present and future perspective.

Pharmacological Reports

64(6), pp. 1291-1304.

Read Abstract (New Window) Read Full (New Window)

Masi G. (2004)

Pharmacotherapy of pervasive developmental disorders in children and adolescents.

CNS Drugs

18(14), pp. 1031-1052

Read Abstract (New Window)

Morrow J. et al. (2006)

Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register.

Journal of Neurology and Neurosurgical Psychiatry

February, 77(2), pp. 193-198

Read Abstract (New Window) Read Full (New Window)

Posey D. J. , Erickson C. A. , McDougle C. J. (2008)

Developing drugs for core social and communication impairment in autism.

Child and Adolescent Psychiatric Clinics of North America

17(4), pp. 787-801

Read Abstract (New Window) Read Full (New Window)

Stigler K. A. , McDougle C. J. (2008)

Pharmacotherapy of irritability in pervasive developmental disorders.

Child and Adolescent Psychiatric Clinics of North America

17(4), pp. 739-752

Read Abstract (New Window)

Uvebrant P. , Bauziene R. (1994)

Intractable epilepsy in children. The efficacy of lamotrigine treatment, including non-seizure related benefits.

Neuopediatrics

25(6), pp. 284-289

Read Abstract (New Window)